Poornima Sood

5.2k total citations
44 papers, 1.9k citations indexed

About

Poornima Sood is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Poornima Sood has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 25 papers in Cardiology and Cardiovascular Medicine and 19 papers in Biomedical Engineering. Recurrent topics in Poornima Sood's work include Coronary Interventions and Diagnostics (24 papers), Mechanical Circulatory Support Devices (19 papers) and Cardiac Structural Anomalies and Repair (18 papers). Poornima Sood is often cited by papers focused on Coronary Interventions and Diagnostics (24 papers), Mechanical Circulatory Support Devices (19 papers) and Cardiac Structural Anomalies and Repair (18 papers). Poornima Sood collaborates with scholars based in United States, Czechia and Canada. Poornima Sood's co-authors include Krishnankutty Sudhir, Mandeep R. Mehra, Gregg W. Stone, Nir Uriel, Ivan Netuka, Daniel J. Goldstein, Dean J. Kereiakes, Charles A. Simonton, Joseph C. Cleveland and Robert J. Applegate and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Poornima Sood

44 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Poornima Sood United States	27	1.7k	1.1k	989	536	283	44	1.9k
Khaldoon Alaswad United States	24	1.5k 0.9×	403 0.4×	1.0k 1.0×	245 0.5×	728 2.6×	146	1.8k
Annemarie E. Engström Netherlands	20	1.3k 0.8×	1.2k 1.1×	740 0.7×	831 1.6×	214 0.8×	38	1.7k
Waqas Ghumman United States	10	2.0k 1.2×	2.2k 2.0×	1.0k 1.0×	987 1.8×	52 0.2×	22	2.5k
Enno Boudriot Germany	13	1.0k 0.6×	627 0.6×	815 0.8×	457 0.9×	327 1.2×	26	1.4k
Pranav Loyalka United States	22	1.6k 1.0×	1.7k 1.6×	874 0.9×	896 1.7×	61 0.2×	104	2.2k
Michiel Morshuis Germany	26	1.9k 1.1×	1.8k 1.7×	783 0.8×	875 1.6×	24 0.1×	155	2.3k
Marc T. Swartz United States	24	1.2k 0.7×	1.1k 1.1×	797 0.8×	364 0.7×	37 0.1×	69	1.6k
G. Sayer United States	21	1.4k 0.9×	1.5k 1.4×	619 0.6×	790 1.5×	20 0.1×	114	1.7k
Thomas A. Vassiliades United States	26	1.6k 1.0×	485 0.5×	1.6k 1.6×	192 0.4×	133 0.5×	65	2.1k
Duc Thinh Pham United States	24	1.4k 0.9×	1.5k 1.4×	683 0.7×	796 1.5×	29 0.1×	88	1.9k

Countries citing papers authored by Poornima Sood

Since Specialization

Citations

This map shows the geographic impact of Poornima Sood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Poornima Sood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Poornima Sood more than expected).

Fields of papers citing papers by Poornima Sood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Poornima Sood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Poornima Sood. The network helps show where Poornima Sood may publish in the future.

Co-authorship network of co-authors of Poornima Sood

This figure shows the co-authorship network connecting the top 25 collaborators of Poornima Sood. A scholar is included among the top collaborators of Poornima Sood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Poornima Sood. Poornima Sood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zile, Michael R., Akshay S. Desai, Maria Rosa Costanzo, et al.. (2022). The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic. European Heart Journal. 43(27). 2603–2618. 27 indexed citations

Mehra, Mandeep R., D. Crandall, Finn Gustafsson, et al.. (2021). Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial. European Journal of Heart Failure. 23(7). 1226–1237. 40 indexed citations

Saeed, Omar, P.C. Colombo, Mandeep R. Mehra, et al.. (2020). Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study. The Journal of Heart and Lung Transplantation. 39(6). 518–525. 30 indexed citations

Lindenfeld, JoAnn, William T. Abraham, Alan S. Maisel, et al.. (2019). Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF). American Heart Journal. 214. 18–27. 36 indexed citations

Mehra, Mandeep R., Christopher T. Salerno, Joseph C. Cleveland, et al.. (2018). Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 138(18). 1923–1934. 43 indexed citations

Uriel, Nir, Diego Medvedofsky, Teruhiko Imamura, et al.. (2018). Echocardiographic Changes in Patients Implanted With a Fully Magnetically Levitated Left Ventricular Assist Device (Heartmate 3). Journal of Cardiac Failure. 25(1). 36–43. 13 indexed citations

Dudek, Dariusz, Adrián Ebner, Robert Sobczyński, et al.. (2018). Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial). The American Journal of Cardiology. 121(12). 1524–1529. 6 indexed citations

Heatley, Gerald J., Poornima Sood, Daniel J. Goldstein, et al.. (2016). Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. The Journal of Heart and Lung Transplantation. 35(4). 528–536. 86 indexed citations

Netuka, Ivan, Tomáš Kvasnička, J Kvasnička, et al.. (2016). Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. The Journal of Heart and Lung Transplantation. 35(7). 860–867. 94 indexed citations

10.

Applegate, Robert J., James Hermiller, Paul Gordon, et al.. (2012). Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention. 7(9). 1030–1042. 3 indexed citations

11.

Lansky, Alexandra J., Somjot Brar, Manejeh Yaqub, et al.. (2012). Impact of Routine Angiographic Follow-Up After Percutaneous Coronary Intervention With Drug-Eluting Stents in the SPIRIT III Randomized Trial at Three Years. The American Journal of Cardiology. 110(1). 21–29. 16 indexed citations

12.

Stone, Gregg W., Ali A. Rizvi, Krishnankutty Sudhir, et al.. (2011). Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 58(1). 19–25. 172 indexed citations

13.

Claessen, Bimmer E., Pieter C. Smits, Dean J. Kereiakes, et al.. (2011). Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions. 4(11). 1209–1215. 100 indexed citations

14.

Hermiller, James, Alexandra J. Lansky, Manejeh Yaqub, et al.. (2011). Low Stent Thrombosis Risk with the XIENCE V® Everolimus-Eluting Coronary Stent: Evidence from Randomized and Single-Arm Clinical Trials. Journal of Interventional Cardiology. 24(4). 326–341. 8 indexed citations

15.

Hermiller, James, Eugenia Nikolsky, Alexandra J. Lansky, et al.. (2011). Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention. 7(3). 307–313. 14 indexed citations

16.

Kereiakes, Dean J., Donald E. Cutlip, Robert J. Applegate, et al.. (2010). Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 56(25). 2084–2089. 67 indexed citations

17.

Caixeta, Adriano, Alexandra J. Lansky, Patrick W. Serruys, et al.. (2010). Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions. 3(12). 1220–1228. 37 indexed citations

18.

Hermiller, James, et al.. (2009). Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial. American Heart Journal. 158(6). 1005–1010. 31 indexed citations

19.

Lansky, Alexandra J., Vivian G. Ng, Ecaterina Cristea, et al.. (2009). Gender‐based evaluation of the XIENCE V™ everolimus‐eluting coronary stent system:. Catheterization and Cardiovascular Interventions. 74(5). 719–727. 34 indexed citations

20.

Wang, Qing, Poornima Sood, C.J. Bol, et al.. (2009). Pharmacokinetic Sub‐Study in the SPIRIT III Randomized and Controlled Trial of XIENCE V^® Everolimus Eluting Coronary Stent System. Journal of Interventional Cardiology. 23(1). 26–32. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact